FTC Approves Final Settlement with CVS Caremark

by Sabrina I. Pacifici on May 15, 2012

News release: “Following a public comment period, the FTC has accepted as final an order with CVS Caremark settling charges that it misrepresented the prices of certain Medicare Part D prescription drugs, including drugs used to treat breast cancer symptoms and epilepsy, at CVS and Walgreens pharmacies. The settlement bars deceptive claims related to Medicare Part D drug prices and requires CVS Caremark to pay $5 million to reimburse affected Medicare Part D consumers for the price discrepancy. The FTC will mail redress checks to eligible consumers when records have been fully processed. Consumers do not need to take any additional action in order to receive their check.”

Posted in Legal Research

Previous post:

Next post: